Avalo Therapeutics (AVTX) EBT Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) EBT Margin (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.76 Mn |
| Dec 31, 2023 | 77,982.00 |
| Sep 30, 2023 | -93,877.00 |
| Jun 30, 2023 | 82,101.00 |
| Mar 31, 2023 | -99,991.00 |
| Dec 31, 2022 | -111,558.00 |
| Sep 30, 2022 | 127,811.00 |
| Jun 30, 2022 | 62,239.00 |
| Mar 31, 2022 | 686,381.00 |
| Dec 31, 2021 | -744,937.00 |
| Sep 30, 2021 | -77,573.00 |
| Jun 30, 2021 | 594,370.00 |
| Mar 31, 2021 | -537,081.00 |
| Dec 31, 2020 | 10,262.00 |
| Sep 30, 2020 | -20,081.00 |
| Jun 30, 2020 | -10,974.00 |
| Mar 31, 2020 | -74,121.00 |
| Dec 31, 2019 | -1,398.00 |
| Sep 30, 2019 | 5,031.00 |
| Jun 30, 2019 | 1,739.00 |